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Canine prostate fluids and seminal plasma contain a major androgen-dependent protein which was identi- 
tied as a proteolytic enzyme exhibiting an Arg-e&erase activity. This protease, as characterized, is shown 
to be present as a two-chain structure held together by at least one disultide bridge and composed of approx- 
imately 220 amino acids. Amino acid sequence determination of both chains has revealed a clear homology 
to other known amino acid sequences of serine proteases. Furthermore, the comparison of the presented 
58 amino acids of the Arg-esterase with the other sequences revealed a very strong homology (larger than 
50%) to members of the kallikrein family. The two chain structure could thus result from autolysis of a 
single chain enzyme in the ‘kallikrein autolysis loop’. Amino acid composition of the canine prostatic en- 
zyme suggests that it is related, but not identical, to pancreatic anine kallikrein. 
Androgen-dependent protease Canine prostate Kallikrein autolysis loop 
1. INTRODUCTION 
Potent proteolytic enzymes, at first detected by 
their fibrinolytic and fibrinogenolytic properties, 
have long been known to exist in seminal plasma 
[ 11. Indeed, some early reports [2,3] have described 
the presence in canine prostatic fluids of numerous 
proteolytic activities including some akin to an 
Arg-esterase activity. Similarly, a kallikrein-like 
enzyme or kininogenase, as evidenced by its ability 
to generate kallidin from crude dog kininogen and 
to induce a significant vasodilator effect in dog, 
was shown to be present in the accessory sex glands 
and in the prostate gland of the guinea pig [4]. 
However, such a kinin-producing activity was not 
observed in the case of the enzymes present in the 
coagulating gland of the rat or in the prostate 
gland of rat, rabbit, dog and man [4]. Recently, 
one of the major protein constituents of canine 
seminal fluid was found to be rapidly synthesized 
when canine prostatic slices were incubated with 
radioactive amino acids; furthermore, both the 
amount synthesized and the kinetics were greatly 
affected by the level of testicular hormones as 
evidenced in castrated animals and upon injection 
of androgens [5]. Furthermore, this major andro- 
gen-dependent protein in canine prostate was 
shown to be an Arg-esterase that was inhibited 
upon addition of diisopropyl fluorophosphate, a 
potent inhibitor of serine proteases [6]. 
* Correspondence should be sent to: Dr Michel ChrC- 
tien, 110 Pine Avenue West, Montreal, Canada 
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The present paper validates the identification of 
that major androgen-dependent protease as being 
a serine protease and, moreover, identifies it 
unambiguously as belonging to the kallikrein fami- 
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ly. Furthermore, this Arg-esterase, in the form 
isolated, possesses a two-chain structure resulting 
from autotysis in a manner analogous to p- 
kallikrein. 
2. MATERIALS AND METHODS 
Native arginine esterase was isolated by chro- 
matofocusing [6]. Only the first peak eluting at pH 
7.3 was used for sequence studies. This fraction 
was found to contain only two protein spots in ap- 
parently equal amounts in two-~mensional non- 
equilibrium pH gel electrophoresis [6]. It was 
dialyzed extensively against distilled water and was 
lyophilized. The heavy fragment arising from 
autolysis was isolated by a procedure involving a 
desalting step on Sephadex G-25 followed by chro- 
matography on CM-Sephadex to remove high 
molecular weight acidic proteins. After desalting 
and lyophilization, the material was subjected to 
non-equilibrium pH gel electrophoresis in tubes as 
described in [7f. The most basic protein was re- 
covered from the gel by electroelution [S]. It was 
desalted over Sephadex G-25 and dialyzed exten- 
sively against distilled water to remove con- 
taminating ampholytes. After lyophilisation, the 
recovered material was found to contain a single 
spot by two-dimensional gel electrophoresis. 
The disulfide bridges of the native Arg-esterase 
were opened by reduction with dithiothreitol and 
the resulting half-cystines were alkylated with 
iodoacetic acid as proposed in 191. The protein was 
desalted on a Sephadex G25 column eluted with 
ammonium bicarbonate 1% and recovered by 
lyophilization. Native, reduced and alkylated Arg- 
esterase were subsequently analyzed by high-per- 
formance liquid chromatography (HPLC) on a 
large pore (330 A) VYDAC C18 column (0.46 x 25 
cm) using 0.1% trifluoroacetic acid as eluant and 
I-propanol as organic modifier. The HPLC ap- 
paratus consisted of a Waters model 204 liquid 
chromatograph equipped with a model 730 in- 
tegrator-plotter and a model 720 system con- 
troller. 
Amino acid analyses were done following acid 
hydrolysis in 5.7 N HCl containing a trace of 
phenol and 0.01% mercaptoeth~ol in vacua at 
108°C. The separation and quantitation of the 
amino acids were performed on a Beckman 121 M 
auto analyzer. 
2 
Automatic amino-terming Edman degradation 
on the native material was performed using a 0.33 
M Quadrol program on a Beckman 890 C se- 
quenator equipped with a Sequemat P6 autocon- 
verter and a model SC-510 controller. Moreover, 3 
mg of Polybrene (Aldrich) and addition of o- 
phthalaldehyde (OPA) (Fluoropa, Pierce Chem) at 
selected cycles suspected to be proline residues 
were both used in [IO]. PTH-amino acid 
derivatives were identified and quantitated using 
PTH-norleucine as internal standard by HPLC 
1111, on a Varian 5560 liquid chromatograph 
equipped with a Vista 402 integrator-plotter and 
with a WISP (Waters) automatic injector. 
3. RESULTS 
Preliminary results obtained while sequencing 
the native enzyme revealed the presence of two 
amino terminal sequences in almost equal propor- 
tion, one of which possessed a Pro residue at cycle 
13. Therefore, the native enzyme was sequenced 
again but, this time, addition of OPA at cycle 13 
allowed the identification of a single sequence as 
shown in fig. 1A. The initial and repetitive yields 
were computed after background correction to be 
4.7 nm and 92.7%, respectively. Not shown on the 
figure is the sequence of the first 12 cycles cor- 
responding to Ala-Val-Ile-Arg-Pro-Gly-Glu-Asp- 
Arg-Ser-His-Asp and representing the second se- 
quence. As can be seen in fig. lA, no amino acid 
derivatives were identified at cycle 7 and 26; both 
of these positions are presumed to be occupied by 
half-cystine. Amino acid sequence analysis of the 
basic Arg-esterase fragment, isolated following 
NEpHGE, is shown in fig. 1B. It can be clearly 
seen that the first 12 residues identified correspond 
entirely with the amino acids identified while se- 
quencing the native enzyme. The initial and 
repetitive yields for that sequence were computed 
after background subtraction to be 9.4 nm and 
94% respectively. Both sequences were not pur- 
sued further because of an increasing background 
probably caused by the methods used during isola- 
tion. 
To further conform the presence of a two-chain 
structure for that protease as suggested by the 
results of the amino acid sequence analysis, the 
native enzyme was purified by reverse-phase 
HPLC as shown in fig. 2A where it can be eluted 
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Fig. 1. Automatic NHz-terminal degradation of native canine Arg-esterase (A) and of a fragment arising from autolysis 
(B). Quantitative yields after background subtraction of PTH-amino acids normalized to a PTH-norleucine internal 
standard are illustrated as a function of residue numbers. The slope and intercept were obtained by a linear regression 
analysis on selected stable PTH-amino acids giving the repetitive and initial yield, respectively. 
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as a single symmetrical peak at around 24 min. 
Amino acid compositions of that material were 
done and the results are presented in table 1. Upon 
reduction and alkylation of the HPLC purified en- 
zyme, two homogeneous components, as deter- 
mined by sequence analysis (results not shown) 
eluting at 23 and 25 min, respectively, can be 
separated, as illustrated in fig. 2B. Amino acid 
compositions of the material under each peak were 
done and the results presented in table 1. As can be 
seen, the Arg-protease is composed of a light chain 
containing 3 half-cystine residues corresponding to 
the early eluting component and of an heavy chain 
containing 7 half-cystine residues corresponding to 
the later eluting peak. That result was independ- 
Tlmo ( min. ) 
Fig. 2. HPLC chromatography of the native (A) and the 
reduced and alkylated (B) canine Arg-esterase on a 
Vydac CIS column eluted with a 0.1% TFA-1-propanol 
gradient at a flow rate of 1 ml/min. 
Table 1 
Amino acid composition of canine prostate ARG- 
esterase 
Amino Light 
acids chair? 
Heavy 
chair? 
Native Canine 
kalli- 
kreinC 
(pan- 
creas) 
Asx 6.3 ( 6) 10.4 (10) 17.3 (17) 25 
Thr 1.9 ( 2) 8.8 ( 9) 13.9 (14) 15 
Ser 4.9 ( 5) 7.5 ( 8) 14.1 (14) 
Glx 12.4 (12) 11.9 (12) 22.7 (23) f: 
Pro 3.3 ( 3) 9.5 (9-10) 13.5 (13-14) 15 
GUY 8.6 ( 9) 13.4 (13) 19.6 (20) 20 
Ala 5.1 ( 5) 6.3 ( 6) 11.2 (11) 15 
Val 10.3 (10) 11.6 (12) 20.5 (20-21) 17 
Met 4.5 (4-5) 5.2 ( 5) 4 
Ile 1.8 ( 2) 4.5 (4-5) 7.3 ( 7) 12 
Leu 6.9 ( 7) 14.0 (14) 22.7 (23) 23 
Tyr 2.7 ( 3) 3.1 ( 3) 4.8 ( 5) 8 
Phe 2.4 ( 2) 2.8 ( 3) 3.9 ( 4) 8 
His 4.3 ( 4) 4.0 ( 4) 8.0 ( 8) 8 
Lys 3.8 ( 4) 12.3 (12) 16.2 (16) 13 
Arg 3.6 ( 4) 3.7 ( 4) 7.2 ( 7) 5 
CM-Cys 3.0 ( 3) 7.0 ( 7) 8 
Trp NDd NDd NDd 4 
Total 81 134-137 207-209 240 
aResults obtained from 24 h hydrolysis 
bResults obtained from duplicate hydrolysis during 24, 
48 and 72 h 
‘Values taken from [20] 
dND, Not determined. 
The compositions were adjusted according to the 
underlined residues. 
ently confirmed by labeling the half-cystine with 
radioactive iodoacetic acid and separation of the 
two components by HPLC; the total recovery of 
radioactivity was found to be 86.3070, whereas the 
radioactivity content corresponded to 34 and 66% 
for the early and later eluting peak, respectively 
(results not shown). Moreover, it can be seen that 
if one makes the summation of the amino acid con- 
tent of each peak and compares the results with the 
total amino acid composition of the native en- 
zyme, they are in very close agreement. The 
resulting amino acid composition thus suggests 
that the Arg-esterase, as isolated from canine 
seminal fluids, should contain ca. 220 amino acids. 
4 
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4. DISCUSSION the disulfide bridges, two chains corresponding to 
15 kDa and 14 kDa, respectively, were released, 
Following the study concerning the effect of the former being able to bind DFP while the latter, 
testicular hormones on synthesis of soluble pro- in view of its electrophoretic heterogeneity, is pro- 
teins by dog prostate slices, it was proposed that bably glycosylated [6]. 
the major androgen-dependent protein seen as a 15 As can be seen in fig. 3, the partial amino acid 
kDa protein could be part of a serine-protease con- sequence of both chains can be compared with the 
sidering its ability to bind DFP [6]. This peptide amino acid sequences of kallikrein-related pro- 
was later shown to be part of a bigger protein ex- teases. The homologies thus range from 49% with 
hibiting a molecular mass of 29.5 kDa as estimated the nerve growth factor y-subunit [ 151 up to 64.4% 
by gel filtration and able to hydrolyze BAEE, a with the porcine pancreatic kallikrein [ 141, whereas 
known Arg-esterase substrate. Upon reduction of it is only 28% with bovine trypsin and chymotryp- 
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Fig. 3. Comparison of the NHz-terminal sequence of the two fragments obtained from canine prostate Arg-esterase (top 
lines) with corresponding sequence aligned by homology of rat pancreatic kallikrein (RPK) [12], rat submaxillary gland 
kallikrein (RSK) [13], pig pancreatic kallikrein (PPK) [14], y-subunit of NGF [15], y-renin [16], rat tonin [17] and mouse 
submaxillary gland kallikrein (MSK) [ 18). Identical residues are enclosed in boxes and the sign l in front of a sequence 
indicates the beginning of an observed autolytic fragment. 
5 
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sin. Moreover, the alignment of both sequences 
confirms the nature of both chains and also con- 
firms the results in [5,6]. Indeed, the early eluting 
peak in HPLC corresponds to the lower molecular 
weight chain and to the NHz-terminal sequence 
starting at Ile-Ile-Gly. . . Therefore, based upon 
the amino acid composition, it should extend up to 
80-85 residues; the Asn-78 found in the porcine 
pancreatic kallikrein and known to be linked to 
carbohydrates could be present and could explain 
the observed electrophoretic heterogeneity. Also, 
the presence of the presumed half-cystine at posi- 
tion 7 is responsible for the linkage to the other 
chain as can be surmised from the homology to 
other kallikreins. The higher molecular weight 
chain corresponding to the later eluting peak 
should comprise the remainder of the molecule (ca. 
137 residues). When compared with other kalli- 
kreins, it is clearly produced by an autolytic cleav- 
age in the known ‘kallikrein autolysis loop’ since 
the beginning of its sequence is very close or other 
observed autolytic sites found in rat submaxillary 
[ 131 and porcine pancreatic [141 kallikrein or the y- 
subunit of NGF [ 151. Moreover, it contains the ac- 
tive site serine (responsible for binding DFP) and 
Asp residues (found at position 12 of the high 
molecular weight fragment in fig. 3). On the other 
hand, it cannot be said, as yet, whether that struc- 
ture of ca. 220 amino acids fully represents the 
complete canine Arg-esterase since some amino 
acids in between the two chains could have been 
lost during the autolytic process. 
Further comparisons can also be made between 
the amino acid composition and the structural 
characteristics of the canine Arg-esterase and of a 
glycoprotein also present in canine prostatic fluid 
[19]; indeed, when one recalculates the amino acid 
composition of the latter according to the data 
reported herein, it can be suggested that both pro- 
teins are identical even though, in the latter case, 
no enzymatic activities were studied. Moreover, 
the amino acid composition of the canine Arg- 
esterase seems to be significantly different from 
the one reported in [20] for the canine pancreatic 
ialiikrein shown in the last column of iable I, even 
when consideri?g the possible losses of some 
amino acids due to autolysis between the two 
chains. Considering that the murine genome en- 
codes numerous highly homologous genes for 
kallikrein [18], it could thus mean that two dif- 
6 
ferent structural genes are expressed in both canine 
tissues, the pancreas and the prostate gland. On 
the other hand, the validity of such an affirmation 
cannot be clearly assessed at the moment. Indeed 
comparison of immunological data and amino acid 
compositions of porcine pancreatic, submaxillary 
gland and urinary kallikrein, as reviewed in [21], 
and also comparison of the amino acid sequence of 
rat submaxillary gland [13] and rat pancreatic [121 
kallikrein where 117 positions out of 118 are iden- 
tical seems to indicate that the same structural gene 
is expressed in different tissues. 
Since it is not yet known whether the canine en- 
zyme is able to release kinins (preliminary data 
[4,5] seem to indicate that it cannot), its similarity 
to the y-subunit together with the high amount 
present in the prostate gland are intriguing. The 
prostate gland of guinea pig, rabbit and bull were 
shown to contain substantial amount of NGF [22] 
but it is not known whether NGF is present in 
substantial amount in the prostate gland of the 
dog. Further data is thus needed either on the 
presence of NGF or upon the nature of the canine 
y-subunit before any conclusions can be made on 
the possible coexistence of NGF and the canine 
Arg-esterase. On the other hand, the presence of a 
kininogenase in human seminal plasma able to 
release kinins from kininogen was reported [23,24] 
whereas previous reports had failed to show pro- 
duction of kinins; the same could hold true for the 
canine Arg-esterase. 
Finally, because of its sensitivity to androgen 
modulation and its now established relationship to 
kallikreins, ‘ group of serine proteases with bio- 
regulatory actions’, the canine Arg-esterase pre- 
sent in seminal fluids should provide an interesting 
marker for the study of benign and malignant 
neoplasia and of the mechanism of steroid hor- 
mone action, the dog prostate being a model well 
suited for both aspects. Further chemical charac- 
terization of the canine Arg-esterase is currently in 
progress in our laboratories. 
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